Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SFDA Approved 434 New Drugs In 2008

This article was originally published in PharmAsia News

Executive Summary

China's State FDA accepted a total of 3,413 applications for drug registrations in 2008. The total number decreased by 75 percent and 18 percent compared to the same period in 2006 and 2007, largely because of a sharp drop in the number of applications of imitation drugs and modified drugs. SFDA approved a total of 434 new drugs for clinical applications, of which 52 are new compounds. The agency approved a total of 165 applications for new drug production, of 119 different drugs; and it approved a total of 99 applications for importation of medicines, involving 83 drugs. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC070893

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel